Practical Guidelines for Diagnosis and Early Management of Drug-induced Liver Injury

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2008 Dec 6

PMID 19058303

Citations 57

Authors

Kazuto Tajiri

Yukihiro Shimizu

Affiliations

Soon will be listed here.

Abstract

The spectrum of drug-induced liver injury (DILI) is both diverse and complex. The first step in diagnosis is a suspicion of DILI based on careful consideration of recent comprehensive reports on the disease. There are some situations in which the suspicion of DILI is particularly strong. Exclusion of other possible etiologies according to the pattern of liver injury is essential for the diagnosis. In patients with suspected DILI, diagnostic scales, such as the Councils for International Organizations of Medical Sciences/Roussel Uclaf Causality Assessment Method (CIOMS/RUCAM) scale, may be helpful for the final diagnosis. Early management of DILI involves prompt withdrawal of the drug suspected of being responsible, according to serum levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP), and total bilirubin (T-Bil). However, as DILI patients may show resolution of liver injury without discontinuation of the drug, it should be carefully evaluated whether the suspected drug should be discontinued immediately with adequate consideration of the importance of the medication.

Citing Articles

Anti-tumor effect and hepatotoxicity mechanisms of psoralen.

Meng D, Dong Y, Shang Q, Sun Z Front Pharmacol. 2024; 15:1442700.

PMID: 39161897 PMC: 11331265. DOI: 10.3389/fphar.2024.1442700.

Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV.

Roen A, Peters L, Wandeler G, Van Der Valk M, Zangerle R, Gunthard H Open Forum Infect Dis. 2024; 11(6):ofae308.

PMID: 38919512 PMC: 11196901. DOI: 10.1093/ofid/ofae308.

The Association Between Antidepressant Use and Drug-Induced Liver Injury: A Nationwide, Population-Based Case-Control Study in Taiwan.

Huang C, You Y, Lai J, Lin C, Hsu H, Hsieh Y Drugs Real World Outcomes. 2024; 11(3):513-520.

PMID: 38837010 PMC: 11365879. DOI: 10.1007/s40801-024-00419-0.

2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats.

Taylor S, Gruen M, KuKanich K, Lascelles B, Monteiro B, Sampietro L J Feline Med Surg. 2024; 26(4):1098612X241241951.

PMID: 38587872 PMC: 11103309. DOI: 10.1177/1098612X241241951.

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors.

Li X, Bo Y, Zeng Q, Diao L, Greene S, Patterson J Front Pharmacol. 2024; 15:1322557.

PMID: 38500768 PMC: 10944885. DOI: 10.3389/fphar.2024.1322557.

References

Hayashi T, Takahashi T, Minami T, Akaike J, Kasahara K, Adachi M . Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia. J Gastroenterol. 2002; 36(11):783-6. DOI: 10.1007/s005350170022. View

Aygun C, Kocaman O, Gurbuz Y, Senturk O, Hulagu S . Clindamycin-induced acute cholestatic hepatitis. World J Gastroenterol. 2007; 13(40):5408-10. PMC: 4171338. DOI: 10.3748/wjg.v13.i40.5408. View

De Valle M, Av Klinteberg V, Alem N, Olsson R, Bjornsson E . Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006; 24(8):1187-95. DOI: 10.1111/j.1365-2036.2006.03117.x. View

Wielgo-Polanin R, Lagarce L, Gautron E, Diquet B, Laine-Cessac P . Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil. Int J Antimicrob Agents. 2005; 26(2):176-8. DOI: 10.1016/j.ijantimicag.2005.04.019. View

Suyama T, Fujiwara H, Takenouchi K, Ito M . Drug eruption and liver injury caused by terfenadine and oxatomide. Eur J Dermatol. 2002; 12(4):385-6. View

Takikawa H, Takamori Y, Kumagi T, Onji M, Watanabe M, Shibuya A . Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting. Hepatol Res. 2003; 27(3):192-195. DOI: 10.1016/s1386-6346(03)00232-8. View

Vuppalanchi R, Liangpunsakul S, Chalasani N . Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?. Am J Gastroenterol. 2006; 102(3):558-62. DOI: 10.1111/j.1572-0241.2006.01019.x. View

Khoo A, Tham L, Lee K, Lim G . Acute liver failure with concurrent bupropion and carbimazole therapy. Ann Pharmacother. 2003; 37(2):220-3. DOI: 10.1177/106002800303700212. View

Buyse S, Vibert E, Sebagh M, Antonini T, Ichai P, Castaing D . Liver transplantation for fulminant hepatitis related to nevirapine therapy. Liver Transpl. 2006; 12(12):1880-2. DOI: 10.1002/lt.20985. View

10.

Watanabe M, Shibuya A . Validity study of a new diagnostic scale for drug-induced liver injury in Japan-comparison with two previous scales. Hepatol Res. 2004; 30(3):148-154. DOI: 10.1016/j.hepres.2004.08.005. View

11.

Kawakami T, Tanaka A, Negoro S, Morisawa Y, Mikami M, Hojo M . Liver injury induced by levothyroxine in a patient with primary hypothyroidism. Intern Med. 2007; 46(14):1105-8. DOI: 10.2169/internalmedicine.46.0086. View

12.

Bauer T, Bircher A . Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization. J Hepatol. 1997; 26(2):429-32. DOI: 10.1016/s0168-8278(97)80062-1. View

13.

Maria V, Victorino R . Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997; 26(3):664-9. DOI: 10.1002/hep.510260319. View

14.

Norris W, Paredes A, Lewis J . Drug-induced liver injury in 2007. Curr Opin Gastroenterol. 2008; 24(3):287-97. DOI: 10.1097/MOG.0b013e3282f9764b. View

15.

Reinus J, Persky S, Burkiewicz J, Quan D, Bass N, Davern T . Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intern Med. 2000; 133(12):964-8. DOI: 10.7326/0003-4819-133-12-200012190-00011. View

16.

Akhtar A, Shaheen M . Jaundice in African-American and Hispanic patients with AIDS. J Natl Med Assoc. 2008; 99(12):1381-5. PMC: 2575931. View

17.

Lucena M, Andrade R, Fernandez M, Pachkoria K, Pelaez G, Duran J . Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology. 2006; 44(4):850-6. DOI: 10.1002/hep.21324. View

18.

Brncic N, Kraus I, Viskovic I, Mijandrusic-Sincic B, Vlahovic-Palcevski V . 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis. Med Sci Monit. 2006; 12(11):CS107-9. View

19.

Aiba T, Takahashi T, Suzuki K, Okoshi S, Nomoto M, Uno K . Liver injury induced by a Japanese herbal medicine, sairei-to (TJ-114, Bupleurum and Hoelen Combination, Chai-Ling-Tang) R1. J Gastroenterol Hepatol. 2007; 22(5):762-3. DOI: 10.1111/j.1440-1746.2006.03373.x. View

20.

Liu Q, Tobias H, Petrovic L . Drug-induced liver injury associated with ezetimibe therapy. Dig Dis Sci. 2007; 52(2):602-5. DOI: 10.1007/s10620-006-9497-2. View